14-3-3ζ, a Novel Androgen-Responsive Gene, Is Upregulated in Prostate Cancer and Promotes Prostate Cancer Cell Proliferation and Survival

Abstract

Purpose: Androgen receptor is an essential transcriptional factor that contributes to the development and progression of prostate cancer. In this study, we investigated the androgen regulation and functional analysis of 14-3-3ζ in prostate cancer. Experimental Design: Using chromatin immunoprecipitation (ChIP) combined with DNA microarray (ChIP-chip) analysis in LNCaP cells, we identified a functional androgen receptor–binding site in the downstream region of the 14-3-3ζ gene. Androgen regulation was examined by quantitative reverse transcription PCR and Western blot analysis. Prostate cancer cells stably expressing 14-3-3ζ and siRNA knockdown were used for functional analyses. We further examined 14-3-3ζ expression in clinical samples of prostate cancer by immunohistochemistry and quantitative reverse transcription PCR. Results: Androgen-dependent upregulation of 14-3-3ζ was validated at the mRNA and protein levels. The 14-3-3ζ gene is favorable for cancer-cell survival, as its ectopic expression in LNCaP cells contributes to cell proliferation and the acquired resistance to etoposide-induced apoptosis. 14-3-3ζ expression was associated with androgen receptor transcriptional activity and prostate-specific antigen (PSA) mRNA expression. Immunoprecipitation indicated that 14-3-3ζ was associated with androgen receptor in the nucleus. Clinicopathologic studies further support the relevance of 14-3-3ζ in prostate cancers, as its higher expression is associated with malignancy and lymph node metastasis. Conclusions: 14-3-3ζ is a novel androgen-responsive gene that activates proliferation, cell survival, and androgen receptor transcriptional activity. 14-3-3ζ may facilitate the progression of prostate cancer. Clin Cancer Res; 18(20); 5617–27. ©2012 AACR.

Coexistence of YWHAZ amplification predicts better prognosis in muscle-invasive bladder cancer with CDKN2A or TP53 loss

“…In prostate cancer, 14-3-3ζ was upregulated by androgen and contributes to cell proliferation and resistance to etoposide-induced apoptosis in LNCaP cells. The higher expression is associated with malignancy and lymph node metastasis [7]. In breast cancers, 14-3-3ζ overexpression occurred in nearly half of breast tumors and was determined to be an independent prognostic factor for reduced disease-free survival.…”

A cancer-related protein 14-3-3ζ is a potential tumor-associated antigen in immunodiagnosis of hepatocellular carcinoma

“…Many previous studies considered 14-3-3ζ as a prognostic marker or therapeutic target for cancer; 14-3-3ζ was found to be a novel androgen-responsive gene that activates proliferation, cell survival, and androgen receptor transcriptional activity and may facilitate the progression of prostate cancer [40]. Recently, the 14-3-3ζ protein was identified as a potential serum biomarker of epithelial ovarian cancer [41, 42].…”

Expression of Androgen and Estrogen Signaling Components and Stem Cell Markers to Predict Cancer Progression and Cancer-Specific Survival in Patients with Metastatic Prostate Cancer

“…Immunohistochemical analysis for AR and Klf4 was performed with the streptavidin-biotin amplification method using an EnVisionþ Visualization Kit (Dako) for AR and Klf4, as previously described (12,26). The primary antibody against AR and Klf4 (1:50 dilution) was applied and incubated at room temperature for 1 hour.…”